General Information of Drug (ID: DMF7HVU)

Drug Name
Isatuximab
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Approved [1]
Plasma cell myeloma 2A83.1 Phase 3 [2]
Affected Organisms
Humans and other mammals
ATC Code
L01FC02: Isatuximab
L01FC: CD38 (Clusters of Differentiation 38) inhibitors
L01F: MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01: ANTINEOPLASTIC AGENTS
L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Cross-matching ID
UNII
R30772KCU0
DrugBank ID
DB14811
TTD ID
D0JB2J

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
2 ClinicalTrials.gov (NCT04270409) Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma. U.S. National Institutes of Health.